Physician profile
Amanda L Strobel
NPI 1164719597
$731.04
in general payments reported to CMS, 2019-2025
18 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $256 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $124.99 | 2023 | |
| Novo Nordisk INC | $75.84 | 2024-2025 | Alhemo, Esperoct, Novoseven |
| Bayer Healthcare Pharmaceuticals INC. | $59.06 | 2025 | |
| Csl Behring | $58.64 | 2024 | Idelvion, Hemgenix |
| Sobi, INC | $52.42 | 2025 | |
| Syndax Pharmaceuticals, INC. | $44.80 | 2025 | |
| Rare Disease Therapeutics, INC. | $43.01 | 2025 | Xromi |
| Jazz Pharmaceuticals INC. | $40.99 | 2024 | |
| Adaptive Biotechnologies Corporation | $35.37 | 2024 | Clonoseq |
| Pfizer INC. | $33.10 | 2025 | |
| Teleflex LLC | $25.75 | 2025 | Arrow |
| Mesoblast, INC. | $23.31 | 2025 | Ryoncil |
| Y-Mabs Therapeutics, INC. | $22.06 | 2024 | Danyelza |
| Springworks Therapeutics, INC. | $21.37 | 2025 | Gomekli |
| Alexion Pharmaceuticals, INC. | $20.92 | 2024 | Ultomiris |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.03 | 2024 | Hemlibra |
| Merck Sharp & Dohme LLC | $17.00 | 2025 | Prevymis |
| Agios Pharmaceuticals, INC. | $15.38 | 2024 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Strobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.